Indeed, p53 activation resulted in decreased expression of potential tumor-supporting genes such as cytokines/chemokines (IL-6, CXCL12), growth factors (PDGF, FGF1, IGF1), signaling molecules (TGFβ1, WNT5) and ECM components (Collagens, Elastin). The gene discussed is ELN; the disease is neoplasm.